Yes—paired blood test trends revealed five groups with different death rates in people with pancreatitis in intensive care. Researchers reviewed records from 2,027 people in Jiangxi, China. They checked their findings against records from 1,381 people in U.S. hospitals. Everyone had acute pancreatitis, a sudden swelling of the pancreas. This organ helps digest food. The team tracked Hematocrit, the share of blood made up of red blood cells. They also tracked BUN (Blood Urea Nitrogen), a measure of waste in the blood. They looked at how both tests changed during the first week of intensive care. Those combined patterns separated people into five groups. In the Chinese records, the kidney-problem group had a 36.6% death rate. The stable group had the lowest rate, at 2.7%. The U.S. records also linked the kidney-problem group to higher death risk. Links between fluid treatment and outcomes differed across groups, too. In the kidney-problem group, more than 4,000 milliliters on day one was linked to higher death risk. These were hospital treatments, not daily drinking targets. Because researchers reviewed past records, they could not prove that fluid amounts caused the outcomes. For BioSocial members, the pattern and setting matter. This study examined two tests together during severe illness. It did not establish risk rules for routine bloodwork in healthy people. When comparing your own results with community peers, dates and illness context can make those conversations more useful than sharing one isolated number. What changes have you noticed in your Hematocrit across blood tests, and what was happening around those dates?